In the News - Q1 Productions

This Week’s Headlines

GOP Releases Amendments to Healthcare Bill

Posted 3/22/17

House Republicans released updated information regarding the recent healthcare bill, the American Health Care Act. The amendments include changes to Medicaid coverage and funding, letting the states opt for block grants versus individual allowances. The updates also included provisions specific to New York State and updated tax credit information, intended to offset the bill’s costs. The American Health Care Act was released earlier this month. Read the full article here.

GE Healthcare Buys Monica Healthcare, Expands Fetal & Maternal Monitoring Department

Posted 3/22/17

GE Healthcare has confirmed the acquisition of Monica Healthcare. The newly bought medical device company, which was once part of the University of Nottingham in England, specializes in fetal and maternal monitoring devices. GE Healthcare has been distributing Monica products in North America since 2015, and is seeking to expand its own fetal and maternal inventory with the purchase. Read the full article here.

Astellas, X-Chem Sign DNA Library Deal to Discover Rare Disease Treatments

Posted 3/22/17

Astellas has joined the likes of Johnson & Johnson, Pfizer, Roche, and Sanofi in X-Chem’s DNA-encoded library. The deal will allow Astellas to expand its research capabilities to focus on rare and niche disease treatments. Astellas is the latest biotech company to see research opportunity in DNA-encoded libraries, which streamline compound identification and combination. Read the full release here.

Eli Lilly Announces Ineffective Drug Price Hikes, Cites Insurance Negotiations

Posted 3/22/17

Eli Lilly has released data showing ineffective drug pricing hikes in 2016. The pharmaceutical manufacturer raised drug prices an estimated 14% last year, but only gained 2.4% in returns. In comparison, a 16.3% hike yielded a 9.4% rise. The company has cited payer discounts as a possible reason for the dwindling numbers, as the average discount amounts to nearly 50% of the overall drug price. Read the full article here.

Study Finds Xarelto More Effective in Reducing Blood Clots than Aspirin

Posted 3/22/17

Xarelto, a Janssen Pharmaceuticals product, was found to be more effective in preventing reoccurring blood clots than aspirin, a recent study suggests. Under the Bayer-funded study, 1.2% and 1.5% of patients taking varying dosages of the drug experienced a reoccurring blood clot, compared with 4.4% of patients who taking aspirin. Cardiologists not involved in the global study welcomed the results, and are looking forward to continued research into affordable blood clot prevention alternatives. Read the full article here.

At Veranex, we can help you with concept through to commercialization by enabling:
• Accelerated speed to market
• Controlled development costs
• Development risk mitigation
• Market viability assessment

At every stage, we navigate our clients to realize efficiencies in cost and time with our integrated and comprehensive solutions.

Visit Sponsor Website

Since TrainingPros was founded in 1997, we have been dedicated to helping our clients find the right consultant for their projects. 25 years later, we are proud to have helped hundreds of clients complete their projects and thousands of consultants find great assignments. We continue to focus on helping our clients and consultants as well as our community as a certified women-owned, award-winning staffing company that works exclusively with Learning & Development professionals to match consultants to client projects.

Visit Sponsor Website

TELCOR is the proven leader of health care software solutions for revenue cycle management (RCM) software and services designed specifically for laboratories. TELCOR RCM, our SaaS solution, and TELCOR Revenue Cycle Services, our billing service, are designed to streamline workflow, improve collections, and provide real-time analytics. Our software and service solutions are designed for the unique challenges and requirements of laboratory specialties and the clients they serve. With full access to data, labs have complete visibility of their data and can track key performance indicators. No other vendor works as hard ensuring you get paid for the work you do.

Visit Sponsor Website

At Tipping Point Media, we pride ourselves on developing innovative, creative, and technically advanced virtual training and digital marketing solutions for the life sciences industry.

We push the limits of what's possible using Augmented and Virtual Reality to create revolutionary experiences proven to increase audience engagement and retention rates.

Our dedicated team of educators, medical experts, certified programmers, and digital renaissance innovators are committed to creating high-quality custom creations that bring your company's vision to life.

Visit Sponsor Website

VantagePoint Performance trains Salespeople to be more fluent and comfortable across different situations needing different sales approaches, and we train Sales Managers to be better coaches and team leaders, with more focus and less stress.

We’re different from the average sales training company because:

We don’t believe that one approach, one system, or one methodology is absolutely superior. All have something to offer, and the “best approach” or “best system” depends on the sales situation. This is what our applied, academic research tells us.
Our use of data science, specifically Machine Learning, helps us learn about our clients more meaningfully. We provide insights from each client’s data to help them understand what drives the success of their top-performing Salespeople and Sales Managers.
We are constantly feeding what we learn back into our training products, and we invest a bigger slice of our total energy into this innovation than the average sales training company. Our clients can access always-refreshed intellectual property and content through our training subscriptions.

Visit Sponsor Website

Policy Reporter, acquired by TrialCard in 2019, provides innovative healthcare software solutions to track payer policies in near real-time and enhances market access for the therapies patients need most. The company’s patented software-driven solutions include a suite of billing and reimbursement tools for providers and laboratories, market intelligence tools for payers, and a suite of market access solutions for life science companies. Its clients include some of the world’s largest pharmaceutical and healthcare companies.

Visit Sponsor Website